HLA class I binding prediction via convolutional neural networks
  Many biological processes are governed by protein-ligand interactions. One
such example is the recognition of self and nonself cells by the immune system.
This immune response process is regulated by the major histocompatibility
complex (MHC) protein which is encoded by the human leukocyte antigen (HLA)
complex. Understanding the binding potential between MHC and peptides can lead
to the design of more potent, peptide-based vaccines and immunotherapies for
infectious autoimmune diseases.
  We apply machine learning techniques from the natural language processing
(NLP) domain to address the task of MHC-peptide binding prediction. More
specifically, we introduce a new distributed representation of amino acids,
name HLA-Vec, that can be used for a variety of downstream proteomic machine
learning tasks. We then propose a deep convolutional neural network
architecture, name HLA-CNN, for the task of HLA class I-peptide binding
prediction. Experimental results show combining the new distributed
representation with our HLA-CNN architecture achieves state-of-the-art results
in the majority of the latest two Immune Epitope Database (IEDB) weekly
automated benchmark datasets. We further apply our model to predict binding on
the human genome and identify 15 genes with potential for self binding.
